Evaluation of treatment adherence in type 1 diabetes: A novel approach

European Journal of Clinical Investigation

Volumn 37, Issue 3, 2007, Pages 207-213

  Kitzler, T M ^a,b   Bachar, M ^c   Skrabal, F ^a   Kotanko, P ^a,b  

^a KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^b RENAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Diabetes mellitus; Metabolic control; Therapy adherence

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; INSULIN; LONG ACTING INSULIN;

ADOLESCENT; ADULT; AGED; ALGORITHM; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; METABOLIC REGULATION; MULTIPLE LINEAR REGRESSION ANALYSIS; MULTIPLE REGRESSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES;

EID: 33847221494     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01771.x     Document Type: Article

References (43)

1. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet 1997;350 (Suppl. 1): SI9-13.
2. Setter SM, Campbell RK, Cahoon CJ. Biochemical pathways for microvascular complications of diabetes mellitus. Ann Pharmacother 2003;37:1858-66.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53.
4. Krishnamurti U, Steffes MW. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem 2001;47:1157-65.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
6. The Diabetes Control and Complications Trial Research Group. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 1996;124:379-88.
7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27 (Suppl. 1):S15-35.
8. Duron F. Intensive insulin therapy in insulin-dependent diabetes mellitus, the results of the diabetes control and complications trial. Biomed Pharmacother 1995;49:278-82.
9. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-9.
10. Bryant W, Greenfield JR, Chisholm DJ, Campbell LV. Diabetes guidelines: easier to preach than to practice? Med J Aust 2006;185 (6):305-9.
11. Bissell P, May CR, Noyce PR. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med 2004;58:851-62.
12. Anderson BJ, Vangsness L, Connell A, Butler D, Goebel-Fabbri A, Laffel LM. Family conflict, adherence, and glycaemic control in youth with short duration type 1 diabetes. Diabet Med 2002;19:635-42.
13. Delamater AM, Jacobson AM, Anderson B, Cox D, Fisher L, Lustman P et al. Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group. Diabetes Care 2001;24:1286-92.
14. Garay-Sevilla ME, Nava LE, Malacara JM, Huerta R, Diaz de Leon J, Mena A et al. Adherence to treatment and social support in patients with non-insulin dependent diabetes mellitus. J Diabetes Complications 1995;9:81-6.
15. Kaufman FR, Halvorson M, Carpenter S. Association between diabetes control and visits to a multidisciplinary pediatric diabetes clinic. Pediatrics 1999;103:948-51.
16. Lo R. Correlates of expected success at adherence to health regimen of people with IDDM. J Adv Nurs 1999;30:418-24.
17. Toljamo M, Hentinen M. Adherence to self-care and glycaemic control among people with insulin-dependent diabetes mellitus. J Adv Nurs 2001;34:780-6.
18. Trief PM, Himes CL, Orendorff R, Weinstock RS. The marital relationship and psychosocial adaptation and glycaemic control of individuals with diabetes. Diabetes Care 2001;24:1384-9.
19. Trief PM, Ploutz-Snyder R, Britton KD, Weinstock RS. The relationship between marital quality and adherence to the diabetes care regimen. Ann Behav Med 2004;27:148-54.
20. Tubiana-Rufi N, Moret L, Czernichow P, Chwalow J. The association of poor adherence and acute metabolic disorders with low levels of cohesion and adaptability in families with diabetic children. The PEDIAB Collaborative Group. Acta Paediatr 1998;87:741-6.
21. Moreland EC, Volkening LK, Lawlor MT, Chalmers KA, Anderson BJ, Laffel LM. Use of blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial. Arch Intern Med 2006;166 (6):689-95.
22. Lewin AB, Heidgerken AD, Geffken GR, Williams LB, Storch EA, Gelfand KM et al. The relation between family factors and metabolic control: the role of diabetes adherence. J Pediatr Psychol 2006;31 (2):174-83.
23. Ellis DA, Frey MA, Naar-King S, Templin T, Cunningham P, Cakan N. Use of multisystemic therapy to improve regimen adherence among adolescents with type 1 diabetes in chronic poor metabolic control: a randomized controlled trial. Diabetes Care 2005;28 (7):1604-10.
24. Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 2004;38:1357-62.
25. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 1997;350:1505-10.
26. Cryer PE. Hypoglycemia is the limiting factor in the management of diabetes. Diabetes Metab Res Rev 1999;15:42-6.
27. Cryer PE, Davis SN, Shamoon H. Hypoglycaemia in diabetes. Diabetes Care 2003;26:1902-12.
28. Dreyer M, Berger M, Kiess W, Lüdecke HJ, Redaelli M, Schatz H et al. Therapie des diabetes mellitus typ 1. Diabetes und Stoffwechsel 2003;12 (Suppl. 2):49-66.
29. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004;27:1218-24.
30. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004;27:2800-5.
31. Camacho PM, Gharib H, Sizemore GW. Hypoglycemia etiology and diagnosis. In: Abu-Lebdeh HS, editor. Evidence-Based Endocrinology. Lippincott Williams & Wilkins; Philadelphia, PA;2003.p.203.
32. Bruno G, Cavallo-Perin P, Bargero G, Borra M, D'Errico N, Pagano G. Glycaemic control and cardiovascular risk factors in type 2 diabetes: a population-based study. Diabet Med 1998;15:304-7.
33. Kaar ML, Akerblom HK, Huttunen NP, Knip M, Sakkinen K. Metabolic control in children and adolescents with insulin-dependent diabetes mellitus. Acta Paediatr Scand 1984;73:102-8.
34. La Greca AM, Auslander WF, Greco P, Spetter D, Fisher EB Jr, Santiago JV. I get by with a little help from my family and friends: adolescents' support for diabetes care. J Pediatr Psychol 1995;20:449-76.
35. Bischof MG, Bernroider E, Ludwig C, Kurzemann S, Kletter K, Waldhausl W et al. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes. Horm Res 2001;56:151-8.
36. Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M et al. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes 1997;46:1172-81.
37. Limbert C, Schwingshandl J, Haas J, Roth R, Borkenstein M. Severe hypoglycemia in children and adolescents with IDDM: frequency and associated factors. J Diabetes Complications 1993;7:216-20.
38. Masharani U, Karam JH, German MS. Pancreatic hormones and diabetes mellitus. In: Greenspan FS, Gardner DG, editors. Basic and Clinical Endocrinology, 7th edn. San Francisco, CA: McGraw-Hill;2004. p.658-46.
39. Mokan M. [Hypoglycemia - occurrence, causes and hormonal counterregulatory mechanisms in healthy persons and in patients with IDDM]. Bratisl Lek Listy 1995;96:311-6.
40. Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004;350:2272-9.
41. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 1997;46:1328-35.
42. Bolli GB, Dimitriadis GD, Pehling GB, Baker BA, Haymond MW, Cryer PE et al. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med 1984;310:1706- 11.
43. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE et al. Assessment of diabetes-related distress. Diabetes Care 1995;18:754-60.